|
WO2010074240A1
|
|
Method for predicting therapeutic effect of chemotherapy
|
|
WO2009113674A1
|
|
Diagnosis of bladder carcinoma
|
|
US2010291622A1
|
|
Novel compound, process for production thereof, and use thereof
|
|
WO2009028705A1
|
|
In vitro culture method for mycobacterium leprae
|
|
WO2009025080A1
|
|
Colorectal cancer marker polypeptide, and method for diagnosis of colorectal cancer
|
|
KR20100053529A
|
|
Method for concentration of low-molecular weight proteins and peptides in body fluid sample
|
|
WO2008129997A1
|
|
Composition of solubilized amnion and use thereof
|
|
WO2008029506A1
|
|
Optical coherence tomography apparatus
|
|
WO2008010604A1
|
|
Blood vessel imaging device and system for analyzing blood vessel distribution
|
|
WO2008001859A1
|
|
OPIOID δ RECEPTOR AGONIST
|
|
WO2008090599A1
|
|
Optical-coherence-tomography apparatus
|
|
US2010203638A1
|
|
Method of Producing High-Density Cultured Tissue and High-Density Cultured Tissue
|
|
US2009002713A1
|
|
Optical Coherence Tomography System
|
|
US2008252901A1
|
|
Wavelength-Tunable Light Source And Optical Coherence Tomography
|
